The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application.
The TGA and Medsafe are currently undertaking a further program of harmonisation work that will progressively increase aspects of regulatory alignment between Australia and New Zealand.
The purpose of one of the harmonisation activities is to develop and publish a common list of colouring substances allowed for use in medicines for oral and topical use (Medicines ingredients - Colours).
A comparison of the two lists of colouring substances allowed in Australia and New Zealand revealed that the New Zealand list contains tartrazine allowed for both oral and topical use in New Zealand, but only allowed for topical use in Australia.
Given this, the TGA conducted a review of toxicity data for tartrazine and produced a report of the findings. As outlined in the report, it is recommended that the TGA allow the use of tartrazine for oral use and to label those products as to tartrazine content in line with New Zealand. This recommendation has since been accepted.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.